- Home
- RXT vs AMLX Comparison
RXT vs AMLX Comparison
Compare RXT & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXT
- AMLX
- Stock Information
- Founded
- RXT 1998
- AMLX 2014
- Country
- RXT United States
- AMLX United States
- Employees
- RXT N/A
- AMLX N/A
- Industry
- RXT EDP Services
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- RXT Technology
- AMLX Health Care
- Exchange
- RXT Nasdaq
- AMLX Nasdaq
- Market Cap
- RXT 509.8M
- AMLX 481.9M
- IPO Year
- RXT 2020
- AMLX 2022
- Fundamental
- Price
- RXT $2.25
- AMLX $4.05
- Analyst Decision
- RXT Hold
- AMLX Buy
- Analyst Count
- RXT 6
- AMLX 7
- Target Price
- RXT $2.47
- AMLX $7.60
- AVG Volume (30 Days)
- RXT 772.4K
- AMLX 786.1K
- Earning Date
- RXT 11-12-2024
- AMLX 11-07-2024
- Dividend Yield
- RXT N/A
- AMLX N/A
- EPS Growth
- RXT N/A
- AMLX N/A
- EPS
- RXT N/A
- AMLX N/A
- Revenue
- RXT $2,771,200,000.00
- AMLX $196,485,000.00
- Revenue This Year
- RXT N/A
- AMLX N/A
- Revenue Next Year
- RXT N/A
- AMLX N/A
- P/E Ratio
- RXT N/A
- AMLX N/A
- Revenue Growth
- RXT N/A
- AMLX N/A
- 52 Week Low
- RXT $1.45
- AMLX $1.58
- 52 Week High
- RXT $3.41
- AMLX $19.95
- Technical
- Relative Strength Index (RSI)
- RXT 37.73
- AMLX 36.50
- Support Level
- RXT $2.47
- AMLX $3.78
- Resistance Level
- RXT $2.46
- AMLX $4.40
- Average True Range (ATR)
- RXT 0.13
- AMLX 0.30
- MACD
- RXT -0.04
- AMLX -0.12
- Stochastic Oscillator
- RXT 16.98
- AMLX 15.52
About RXT Rackspace Technology Inc.
Rackspace Technology Inc is an end-to-end, hybrid, multi cloud technology services company. It designs, builds and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services; Data; Colocation; Cloud; Managed Hosting; Professional Services; and Security & Compliance. It operates in segments namely, Private Cloud, and Public Cloud. It generates revenue through the sale of consumption-based contracts for its service offerings and from the sale of professional services related to designing and building custom solutions.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder.